Join the club for FREE to access the whole archive and other member benefits.

Rapamycin shows a sixty percent life expectancy increase in mice model


Key points from article :

Rapamycin is not a dangerous drug if used properly and responsibly.

Its immuno-suppressive properties are not a contraindication for its use.

At anti-ageing doses, rapamycin eliminates hyperimmunity rather than suppresses immunity.

In middle-aged mice, just 3 months of high-dose rapamycin treatment increased life expectancy up to 60%.

The study was published by Roswell Park Comprehensive Cancer Center.

Detailed history and review of current understanding of Rapamycin and longevity

Mentioned in this article:

Click on resource name for more details.

Alan S. Green

Board certified in Anatomic, Clinical and Forensic Pathology doctor


Ensuring safety of drugs, medical supplies and food which is used daily.

Mikhail Blagosklonny

Professor of oncology at the Roswell Park Cancer Institute

Roswell Park Comprehensive Cancer Center

First center in USA focused on cancer research and treatment